XML 116 R30.htm IDEA: XBRL DOCUMENT
v3.19.3

Stockholders' Equity (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2019
Stockholders' Equity Note [Abstract] |
Schedule of preferred stock dividend declaration and payment | The following table presents cash dividends declared by the Company on its Series B Preferred Stock from January 1, 2019 through September 30, 2019:
Declaration Date |  | Record Date |  | Payment Date |  | Dividend Per Share
August 9, 2019 |  | August 30, 2019 |  | September 30, 2019 |  | $ | 0.46875 |
May 20, 2019 |  | June 3, 2019 |  | June 28, 2019 |  | 0.46875 |
February 15, 2019 |  | March 4, 2019 |  | March 29, 2019 |  | 0.46875 |
Schedule of cash dividends declared on common stock | The following table presents cash dividends declared by the Company on its common stock from January 1, 2019 through September 30, 2019:
Declaration Date (1) |  | Record Date |  | Payment Date |  | Dividend Per Share |
September 12, 2019 |  | September 30, 2019 |  | October 31, 2019 |  | $ | 0.20 |  | (1)
June 12, 2019 |  | July 1, 2019 |  | July 31, 2019 |  | 0.20 |  |
March 6, 2019 |  | March 29, 2019 |  | April 30, 2019 |  | 0.20 |  |
(1) At September 30, 2019, the Company had accrued dividends and dividend equivalents payable of $90.6 million related to the common stock dividend declared on September 12, 2019.
Schedule of sale of stock | The table below presents information with respect to shares of the Company’s common stock issued through public offerings during the year ended December 31, 2018:
Share Issue Date |  | Shares Issued |  | Gross Proceeds Per Share |  | Gross Proceeds
(In Thousands, Except Per Share Amounts) |  |  |  |  |  |  |
August 7, 2018 |  | 50,875 |  | (1) | $7.78 |  | $395,807 | (1)
(1) Includes approximately 875,000 shares issued on September 5, 2018 pursuant to the exercise of the underwriters’ option to purchase additional shares. The Company incurred approximately $6.4 million of underwriting discounts and related expenses in connection with this equity offering.
Schedule of changes in balances of each component of the entity's AOCI | The following table presents changes in the balances of each component of the Company’s AOCI for the three and nine months ended September 30, 2019:
|  | Three Months Ended September 30, 2019 |  | Nine Months Ended September 30, 2019
(In Thousands) |  | Net Unrealized Gain/(Loss) on AFS Securities |  | Net (Loss) on Swaps |  | Total AOCI |  | Net Unrealized Gain/(Loss) on AFS Securities |  | Net Gain/(Loss) on Swaps |  | Total AOCI
Balance at beginning of period |  | $ | 439,898 |  |  | $ | (28,114 | ) |  | $ | 411,784 |  |  | $ | 417,167 |  |  | $ | 3,121 |  |  | $ | 420,288 |
OCI before reclassifications |  | 5,483 |  |  | (233 | ) |  | 5,250 |  |  | 50,085 |  |  | (30,384 | ) |  | 19,701 |
Amounts reclassified from AOCI (1) |  | (14,499 | ) |  | (685 | ) |  | (15,184 | ) |  | (36,370 | ) |  | (1,769 | ) |  | (38,139 | )
Net OCI during the period (2) |  | (9,016 | ) |  | (918 | ) |  | (9,934 | ) |  | 13,715 |  |  | (32,153 | ) |  | (18,438 | )
Balance at end of period |  | $ | 430,882 |  |  | $ | (29,032 | ) |  | $ | 401,850 |  |  | $ | 430,882 |  |  | $ | (29,032 | ) |  | $ | 401,850 |
(1) See separate table below for details about these reclassifications. (2) For further information regarding changes in OCI, see the Company’s consolidated statements of comprehensive income/(loss). The following table presents changes in the balances of each component of the Company’s AOCI for the three and nine months ended September 30, 2018:
|  | Three Months Ended September 30, 2018 |  | Nine Months Ended September 30, 2018
(In Thousands) |  | Net Unrealized Gain/(Loss) on AFS Securities |  | Net Gain on Swaps |  | Total AOCI |  | Net Unrealized Gain/(Loss) on AFS Securities |  | Net (Loss)/Gain on Swaps |  | Total AOCI
Balance at beginning of period |  | $ | 548,551 |  |  | $ | 16,160 |  |  | $ | 564,711 |  |  | $ | 620,648 |  |  | $ | (11,424 | ) |  | $ | 609,224 |
OCI before reclassifications |  | (34,278 | ) |  | 5,390 |  |  | (28,888 | ) |  | (90,250 | ) |  | 32,974 |  |  | (57,276 | )
Amounts reclassified from AOCI (1) |  | (9,455 | ) |  | — |  |  | (9,455 | ) |  | (25,580 | ) |  | — |  |  | (25,580 | )
Net OCI during the period (2) |  | (43,733 | ) |  | 5,390 |  |  | (38,343 | ) |  | (115,830 | ) |  | 32,974 |  |  | (82,856 | )
Balance at end of period |  | $ | 504,818 |  |  | $ | 21,550 |  |  | $ | 526,368 |  |  | $ | 504,818 |  |  | $ | 21,550 |  |  | $ | 526,368 |
(1) See separate table below for details about these reclassifications. (2) For further information regarding changes in OCI, see the Company’s consolidated statements of comprehensive income/(loss).
Information about the significant amounts reclassified out of the entity's AOCI | The following table presents information about the significant amounts reclassified out of the Company’s AOCI for the three and nine months ended September 30, 2019:
|  | Three Months Ended September 30, 2019 |  | Nine Months Ended September 30, 2019 |  |
Details about AOCI Components |  | Amounts Reclassified from AOCI |  | Affected Line Item in the Statement Where Net Income is Presented
(In Thousands) |  |  |  |  |  |
AFS Securities: |  |  |  |  |  |
Realized gain on sale of securities |  | $ | (14,499 | ) |  | $ | (36,370 | ) |  | Net realized gain on sales of residential mortgage securities
Total AFS Securities |  | $ | (14,499 | ) |  | $ | (36,370 | ) |  |
Swaps designated as cash flow hedges: |  |  |  |  |  |
Amortization of de-designated hedging instruments |  | (685 | ) |  | (1,769 | ) |  | Other, net
Total Swaps designated as cash flow hedges |  | $ | (685 | ) |  | $ | (1,769 | ) |  |
Total reclassifications for period |  | $ | (15,184 | ) |  | $ | (38,139 | ) |  |
The following table presents information about the significant amounts reclassified out of the Company’s AOCI for the three and nine months ended September 30, 2018:
|  | Three Months Ended September 30, 2018 |  | Nine Months Ended September 30, 2018 |  |
Details about AOCI Components |  | Amounts Reclassified from AOCI |  | Affected Line Item in the Statement Where Net Income is Presented
(In Thousands) |  |  |  |  |  |
AFS Securities: |  |  |  |  |  |
Realized gain on sale of securities |  | $ | (9,455 | ) |  | $ | (25,580 | ) |  | Net realized gain on sales of residential mortgage securities
Total AFS Securities |  | $ | (9,455 | ) |  | $ | (25,580 | ) |  |
Total reclassifications for period |  | $ | (9,455 | ) |  | $ | (25,580 | ) |  |

X
- Definition Tabular disclosure of information pertaining to declaration and payment of dividends on preferred stock. This item may also include dates pertaining to declaration, recording and payment of dividends on preferred stock, the amount of dividends declared or paid in aggregate as well as for each share. + References No definition available. + Details
Name: | mfa_ScheduleOfPreferredStockDividendDeclarationAndPaymentTableTextBlock
Namespace Prefix: | mfa_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of information related to dividends declared, including paid and unpaid dividends. + References No definition available. + Details
Name: | us-gaap_DividendsDeclaredTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of information about items reclassified out of accumulated other comprehensive income (loss). + References No definition available. + Details
Name: | us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the components of accumulated other comprehensive income (loss). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 14A -URI http://asc.fasb.org/extlink&oid=118930883&loc=SL7669686-108580 + Details
Name: | us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of sales of stock or previously unissued stock made by subsidiary or equity method investee to investors outside the consolidated group. This includes stock issued in a business combination in exchange for shares of an acquired entity. + References No definition available. + Details
Name: | us-gaap_ScheduleOfSaleOfStockBySubsidiaryOrEquityMethodInvesteeDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration